ITI-1284 10 mg: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Phase breakdown

Conditions being studied

Recruiting trials involving ITI-1284 10 mg

• Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
  NCT06701903 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 51 locations
• Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
  NCT06480383 · Phase: Phase 2 · Ages: No age limits stated · Sex: All (male and female) · 56 locations

Common questions

How many recruiting trials involve ITI-1284 10 mg?

2 recruiting trials across 2 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.